Taiwan · Delayed Price · Currency is TWD Sofiva Genomics Statistics
Total Valuation
Sofiva Genomics has a market cap or net worth of TWD 665.08 million. The enterprise value is 595.25 million.
| Market Cap | 665.08M |
| Enterprise Value | 595.25M |
Important Dates
The last earnings date was Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | Jun 27, 2025 |
Share Statistics
Sofiva Genomics has 21.59 million shares outstanding. The number of shares has increased by 0.42% in one year.
| Current Share Class | 21.59M |
| Shares Outstanding | 21.59M |
| Shares Change (YoY) | +0.42% |
| Shares Change (QoQ) | -5.06% |
| Owned by Insiders (%) | 5.59% |
| Owned by Institutions (%) | n/a |
| Float | 12.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.64 |
| PB Ratio | 1.05 |
| P/TBV Ratio | 1.06 |
| P/FCF Ratio | 32.29 |
| P/OCF Ratio | 28.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.76, with an EV/FCF ratio of 28.90.
| EV / Earnings | -81.93 |
| EV / Sales | 1.46 |
| EV / EBITDA | 17.76 |
| EV / EBIT | n/a |
| EV / FCF | 28.90 |
Financial Position
The company has a current ratio of 2.90, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.90 |
| Quick Ratio | 2.23 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 5.76 |
| Debt / FCF | 2.20 |
| Interest Coverage | -34.15 |
Financial Efficiency
Return on equity (ROE) is -1.05% and return on invested capital (ROIC) is -3.17%.
| Return on Equity (ROE) | -1.05% |
| Return on Assets (ROA) | -2.86% |
| Return on Invested Capital (ROIC) | -3.17% |
| Return on Capital Employed (ROCE) | -5.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.53 |
| Inventory Turnover | 6.53 |
Taxes
| Income Tax | -1.49M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.22% in the last 52 weeks. The beta is 0.11, so Sofiva Genomics's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -39.22% |
| 50-Day Moving Average | 31.49 |
| 200-Day Moving Average | 36.05 |
| Relative Strength Index (RSI) | 46.88 |
| Average Volume (20 Days) | 6,877 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sofiva Genomics had revenue of TWD 406.32 million and -7.27 million in losses. Loss per share was -0.34.
| Revenue | 406.32M |
| Gross Profit | 106.51M |
| Operating Income | -34.90M |
| Pretax Income | -8.20M |
| Net Income | -7.27M |
| EBITDA | -7.94M |
| EBIT | -34.90M |
| Loss Per Share | -0.34 |
Balance Sheet
The company has 114.85 million in cash and 45.22 million in debt, giving a net cash position of 69.64 million or 3.22 per share.
| Cash & Cash Equivalents | 114.85M |
| Total Debt | 45.22M |
| Net Cash | 69.64M |
| Net Cash Per Share | 3.22 |
| Equity (Book Value) | 633.80M |
| Book Value Per Share | 30.93 |
| Working Capital | 162.11M |
Cash Flow
In the last 12 months, operating cash flow was 23.16 million and capital expenditures -2.57 million, giving a free cash flow of 20.60 million.
| Operating Cash Flow | 23.16M |
| Capital Expenditures | -2.57M |
| Free Cash Flow | 20.60M |
| FCF Per Share | 0.95 |
Margins
Gross margin is 26.21%, with operating and profit margins of -8.59% and -1.79%.
| Gross Margin | 26.21% |
| Operating Margin | -8.59% |
| Pretax Margin | -2.02% |
| Profit Margin | -1.79% |
| EBITDA Margin | -1.95% |
| EBIT Margin | -8.59% |
| FCF Margin | 5.07% |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 0.97%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 0.97% |
| Dividend Growth (YoY) | 50.77% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.42% |
| Shareholder Yield | 0.55% |
| Earnings Yield | -1.09% |
| FCF Yield | 3.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sofiva Genomics has an Altman Z-Score of 5.74 and a Piotroski F-Score of 2.
| Altman Z-Score | 5.74 |
| Piotroski F-Score | 2 |